The institute
Organizational
Scientific Axes
Teams
Platforms
Members
Productions
Events
News
Jobs
Education
Sustainable dev.
Contact
Login
Search
Intranet
Theme
An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
Publication: Beta-delayed neutron radioactivity of $^{15}$B
Team: Molecular pathophysiology of phospholipases A2 and their mediators
Sophie BERAUD-DUFOUR
